Real-life Management and Therapeutic Outcome of Patients With Chronic Rhinitis and Chronic Urticaria in Thailand

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-01-31

Study Completion Date

2015-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Observation study of patients with chronic rhinitis or chronic urticaria in Thailand

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Antiplatelet Therapy in Chronic Urticaria

NCT06268470

Chronic Urticaria

ACTIVE_NOT_RECRUITING PHASE2

Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais

NCT01115595

Rhinitis, Allergic, Perennial

COMPLETED PHASE4

The Prevalence and Clinical Characteristics of Children With Local Allergic Rhinitis

NCT02271620

Other Allergic Rhinitis

COMPLETED NA

The Development of Allergic Rhinitis in Children Previously Diagnosed as Nonallergic Rhinitis

NCT01068808

Allergic Rhinitis (Disorder)

COMPLETED

Acquisition and Long-term Observation of Patients With Severe Allergic Reactions

NCT05210543

Anaphylaxis

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All patients presenting with symptoms of chronic rhinitis for at least 12 consecutive or non-consecutive weeks per years or symptoms of chronic urticaria for at least 6 weeks will be asked to complete the case report forms asking for details of symptom characteristics, risk factors, personal habits, underlying diseases, and quality of life at the first visit. Investigation results, final diagnosis, and therapeutic interventions will also be recorded by the responsible allergist. On every follow-up appointment, patient symptoms, aggravating factors, medication use and side effects will be completed by patients. New findings, associated diseases, and prescriptions will be completed by allergist. The unfilled variables by patients will be asked in the following visit. Any "non-reported" variables those are unable to retrieve will be treated as missing data for data analysis. The estimated sample size is about 200 new cases per year.

Patient demographic data, clinical presentations, and associated diseases will be reported. The association between clinical characteristics and quality of life will be analyzed. The relationship between clinical manifestations and therapeutic outcomes will be determined.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Allergic Rhinitis Non-allergic Rhinitis Chronic Urticaria

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients diagnosed with chronic rhinitis or chronic urticaria

Patients diagnosed with chronic rhinitis/urticaria and followed-up at Allergy Clinics, Chulalongkorn University

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Have symptoms of chronic rhinitis for at least 12 consecutive or non-consecutive weeks per year or symptoms of chronic urticaria for at least 6 weeks